Carter Denise P. 4
4 · Quoin Pharmaceuticals, Ltd. · Filed Dec 10, 2024
Insider Transaction Report
Form 4
Carter Denise P.
DirectorChief Operating Officer
Transactions
- Award
Share Option (Right to Buy)
2024-12-09+536,609→ 536,609 totalExercise: $0.78Exp: 2034-12-09→ ADS (536,609 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F2]The option vests in four annual installments with 20% vesting on each of December 9, 2025, 2026 and 2027 and 40% vesting on December 9, 2028.